- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/58 - BenzoxazolesHydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Patent holdings for IPC class C07D 263/58
Total number of patents in this class: 415
10-year publication summary
34
|
34
|
23
|
31
|
26
|
16
|
19
|
19
|
22
|
14
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Shionogi & Co., Ltd. | 858 |
12 |
Alkermes Pharma Ireland Limited | 269 |
11 |
Takeda Pharmaceutical Company Limited | 2714 |
7 |
Gilead Sciences, Inc. | 2037 |
7 |
Novartis AG | 10847 |
6 |
The Johns Hopkins University | 5667 |
6 |
Cardioxyl Pharmaceuticals, Inc. | 49 |
6 |
Kowa Company, Ltd. | 1195 |
6 |
The Regents of the University of California | 19898 |
5 |
The General Hospital Corporation | 4726 |
5 |
CHDI Foundation, Inc. | 108 |
5 |
Merck Patent GmbH | 5830 |
4 |
President and Fellows of Harvard College | 5975 |
4 |
Almirall, S.A. | 492 |
4 |
Daiichi Sankyo Company, Limited | 1863 |
4 |
Eastern Virginia Medical School | 66 |
4 |
Ewha University-industry Collaboration Foundation | 727 |
4 |
Janssen Sciences Ireland UC | 183 |
4 |
The Regents of the University of California, Santa Cruz | 19 |
4 |
Thomas Jefferson University | 532 |
4 |
Other owners | 303 |